Abstract:A label‐free electrochemical immunosensor based on the liquid crystal (E)‐1‐decyl‐4‐[(4‐decyloxyphenyl)diazenyl]pyridinium bromide (Br−Py), together with heparin‐stabilized gold nanoparticles (AuNP‐Hep) and Nafion is proposed for the determination of prostate‐specific antigen (PSA). The Br−Py liquid crystal presented redox properties and good film‐forming abilities on the electrode surface, and thus it is a suitable alternative as a redox probe for a label‐free electrochemical immunosensor, which could simplif… Show more
“…The procedure for the synthesis of gold nanoparticles stabilized with heparin (AuNPs-Hep) was carried out as described by Talamini et al 33 Initially, 100 μL of 0.12 mol L −1 HAuCl 4 was added to 10.0 mL of heparin solution (0.5% w/v). After that, 200 μL of NaBH 4 (20 mmol L −1 ) was added and the solution was kept under agitation for 30 minutes.…”
Section: Methodsmentioning
confidence: 99%
“…31,32 Heparin can act as a stabilizing agent because it has an abundance of functional groups, such as ether oxygen, hydroxyl and sulphonic, which can be anchored on the metal surface through ion–dipole interactions. 33 In addition, the sulfonic groups of heparin can mainly interact with gold nanoparticles (AuNPs). AuNPs are utilized to enhance the sensitivity of electrochemical sensors, because of their excellent catalytic and conductive properties.…”
A conductive nanocomposite consisting of heparin-stabilized gold nanoparticles embedded in graphene was prepared and characterized to develop an electrochemical sensor for the determination of esculetin in tea and jam samples....
“…The procedure for the synthesis of gold nanoparticles stabilized with heparin (AuNPs-Hep) was carried out as described by Talamini et al 33 Initially, 100 μL of 0.12 mol L −1 HAuCl 4 was added to 10.0 mL of heparin solution (0.5% w/v). After that, 200 μL of NaBH 4 (20 mmol L −1 ) was added and the solution was kept under agitation for 30 minutes.…”
Section: Methodsmentioning
confidence: 99%
“…31,32 Heparin can act as a stabilizing agent because it has an abundance of functional groups, such as ether oxygen, hydroxyl and sulphonic, which can be anchored on the metal surface through ion–dipole interactions. 33 In addition, the sulfonic groups of heparin can mainly interact with gold nanoparticles (AuNPs). AuNPs are utilized to enhance the sensitivity of electrochemical sensors, because of their excellent catalytic and conductive properties.…”
A conductive nanocomposite consisting of heparin-stabilized gold nanoparticles embedded in graphene was prepared and characterized to develop an electrochemical sensor for the determination of esculetin in tea and jam samples....
“…This configuration produces a signal-off sensor where the change in signal is dictated by steric hindrance caused by surface capture of PSA. 39,55,44,47,51,56 Çevik et al constructed a direct detection platform using Fc-cored polyamidiamine dendrimers (Fc-PAMAM) deposited on Au electrode (Fig. 4d).…”
Electrochemical biosensors hold great promise for enabling clinical analysis of biomarkers at the point-of-care. This is particularly of interest for cancer management due to the importance of early diagnostics as well as the critical need for frequent treatment monitoring. We have reviewed clinically-relevant electrochemical biosensors that have been developed over the past five years for the analysis of prostate specific antigen (PSA), a model protein target for prostate cancer management. We have critically evaluated the key performance metrics of these biosensors for clinical translation: limit-of-detection, linear range, and recovery rate in bodily fluids. These PSA electrochemical biosensors can be broadly categorized as sandwich assays, direct detection assays, and indirect detection assays. Among these, indirect detection assays deliver the lowest limit-of-detection. We have identified the development of multiplexed assays for detecting a panel of cancer biomarkers that includes a combination of protein and nucleic acids targets as a key priority for future development.
“…The unique electro-optical properties of liquid crystal are promising toward the development of a simple and reliable sensing platforms for the quantification of biomolecules. For the most part, the optical properties of LC are exploited to detect molecules [ 33 , 35 , 36 , 37 , 38 ] and in a number of biosensing systems that employ electrochemical detection [ 39 , 40 , 41 ].…”
According to the World Health Organization (WHO), cardiovascular diseases (CVDs) are the leading cause of mortality and morbidity worldwide. The development of electrochemical biosensors for CVD markers detection, such as cardiac troponin I (cTnI), becomes an important diagnostic strategy. Thus, a glassy carbon electrode (GCE) was modified with columnar liquid crystal (LCcol) and gold nanoparticles stabilized in polyallylamine hydrochloride (AuNPs–PAH), and the surface was employed to evaluate the interaction of the cTnI antibody (anti-cTnI) and cTnI for detection in blood plasma. Morphological and electrochemical investigations were used in the characterization and optimization of the materials used in the construction of the immunosensor. The specific interaction of cTnI with the surface of the immunosensor containing anti-cTnI was monitored indirectly using a redox probe. The formation of the immunocomplex caused the suppression of the analytical signal, which was observed due to the insulating characteristics of the protein. The cTnI–immunosensor interaction showed linear responses from 0.01 to 0.3 ng mL−1 and a low limit of detection (LOD) of 0.005 ng mL−1 for linear sweep voltammetry (LSV) and 0.01 ng mL−1 for electrochemical impedance spectroscopy (EIS), showing good diagnostic capacity for point-of-care applications.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.